John Saharek
Corporate Officer/Principal en HARROW, INC. .
Fortuna: 2 M $ al 30/04/2024
Perfil
John P.
Saharek is currently the President & Chief Executive Officer at ImprimisRx LLC since 2012 and the Chief Commercial Officer at Harrow, Inc. since 2012.
Previously, he worked as the Vice President-Business Development at Surmodics, Inc. from 2006 to 2011.
He also held the position of Head-US Marketing & Strategy at Thrombogenics, Inc. Mr. Saharek completed his undergraduate degree at Central Connecticut State University and obtained an MBA from the University of Hartford.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HARROW, INC.
0.71% | 16/04/2024 | 249 803 ( 0.71% ) | 2 M $ | 30/04/2024 |
Cargos activos de John Saharek
| Empresas | Cargo | Inicio |
|---|---|---|
| HARROW, INC. | Corporate Officer/Principal | 01/02/2015 |
| ImprimisRx LLC | Director Ejecutivo | 02/01/2024 |
Antiguos cargos conocidos de John Saharek.
| Empresas | Cargo | Fin |
|---|---|---|
| SURMODICS, INC. | Corporate Officer/Principal | 01/07/2011 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Ventas & Marketing | - |
Formación de John Saharek.
| University of Hartford | Masters Business Admin |
| Central Connecticut State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| HARROW, INC. | Health Technology |
| SURMODICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
| ImprimisRx LLC |
- Bolsa de valores
- Insiders
- John Saharek
